Real-time enrollment status for this stargardt disease clinical trial
Current Status
Recruiting
Checked: October 15, 2026 at 2:36 AM UTC
| NCT Number | NCT07734064 |
| Recruiting Status | Recruiting |
| Condition | Stargardt Disease |
| Phase | PHASE1 |
| Target Enrollment | 30 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Astellas Institute for Regenerative Medicine |
| Last Updated on CT.gov | September 16, 2026 (4 weeks ago) |
As of October 15, 2026: Clinical trial NCT07734064 is currently recruiting participants. This phase1 study for stargardt disease is actively seeking new participants at 3 locations across the United States. The study is sponsored by Astellas Institute for Regenerative Medicine. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07734064 is actively recruiting participants as of October 15, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07734064 was last updated 4 weeks ago (September 16, 2026). HelloStudys verifies this status automatically.